Adoptive T-cell therapy with hexon-specific THELPER-1 cells as a treatment for refractory adenovirus infection after HSCT (original) (raw)
Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation
Robert Beck
British Journal of Haematology, 2006
View PDFchevron_right
Multicenter phase 1/2 application of adenovirus-specific T cells in high-risk pediatric patients after allogeneic stem cell transplantation
Kimberly Gilmour
Cytotherapy, 2018
View PDFchevron_right
Combined CD8(+) and CD4(+) adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection
M. Van Tol
2010
View PDFchevron_right
Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I/II multicenter clinical trial
Cécile Pochon
Journal of hematology & oncology, 2017
View PDFchevron_right
Interferon-γ capture T cell therapy for persistent Adenoviraemia following allogeneic haematopoietic stem cell transplantation
Hong Zhan, Kimberly Gilmour
British Journal of Haematology, 2013
View PDFchevron_right
Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation
Johann Greil
British Journal of Haematology, 2005
View PDFchevron_right
Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation
Theresa Kaeuferle
Journal of Hematology & Oncology
View PDFchevron_right
Third-party virus-specific T cells eradicate adenoviraemia but trigger bystander graft-versus-host disease
Stuart Adams
British Journal of Haematology, 2011
View PDFchevron_right
Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation
Beate Kampmann
British Journal of Haematology, 2005
View PDFchevron_right
Adenovirus infections following haematopoietic cell transplantation: is there a role for adoptive immunotherapy?
Suparno Chakrabarti
Bone Marrow Transplantation, 2000
View PDFchevron_right
Poor outcome of adenovirus infections in adult hematopoietic stem cell transplant patients with sustained adenovirus viremia
L. Pérez-bercoff
Transplant Infectious Disease, 2010
View PDFchevron_right
Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation
Andreas Moosmann
Journal of Clinical Virology, 2016
View PDFchevron_right
Capture and generation of adenovirus specific T cells for adoptive immunotherapy
Maurizio Costabile
British Journal of Haematology, 2007
View PDFchevron_right
Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation
annaleen louwes
Blood, 2009
View PDFchevron_right
Adoptive T Cell Therapy Strategies for Viral Infections in Patients Receiving Haematopoietic Stem Cell Transplantation
Stephen Todryk
Cells
View PDFchevron_right
T-cell therapy: a powerful tool for the management of viral infections and relapse post hematopoietic stem cell transplantation
annaleen louwes
Expert Review of Hematology, 2012
View PDFchevron_right
Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery
Suparno Chakrabarti
Blood, 2002
View PDFchevron_right
Antiviral T Cells for Adenovirus in the Pretransplant Period: A Bridge Therapy for Severe Combined Immunodeficiency
Haili Lang
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2018
View PDFchevron_right
High Titers of Pre-existing Adenovirus Serotype-Specific Neutralizing Antibodies in the Host Predict Viral Reactivation After Allogeneic Stem Cell Transplantation in Children
Els Jol-van der Zijde
Clinical Infectious Diseases, 2011
View PDFchevron_right
High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy
Morris Kletzel, Ben Katz
Pediatric Transplantation, 2008
View PDFchevron_right
Scheduled administration of virus-specific T cells for viral prophylaxis after pediatric allogeneic stem cell transplant
Dakota Lipps
Blood Advances
View PDFchevron_right
Management of adenovirus infection in patients after haematopoietic stem cell transplantation: State-of-the-art and real-life current approach: A position statement on behalf of the Infectious Diseases Working Party of the European Society of Blood and Marrow Transplantation
Prashant Hiwarkar
Reviews in medical virology, 2018
View PDFchevron_right
Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells
Agnes Yong
Blood advances, 2017
View PDFchevron_right
Incidence of Adenovirus Infection in Hematopoietic Stem Cell Transplantation Recipients: Findings from the AdVance Study
Toni Petterson
Biology of Blood and Marrow Transplantation, 2018
View PDFchevron_right
Virus-Specific T Cells: Promising Adoptive T Cell Therapy Against Infectious Diseases Following Hematopoietic Stem Cell Transplantation
elham roshandel
Advanced Pharmaceutical Bulletin
View PDFchevron_right
Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome
Patricia Ribaud, A. Bergeron
Haematologica-the Hematology Journal, 2007
View PDFchevron_right
Human adenovirus infection in patients subjected to allogeneic hematopoietic stem cell transplantation – a three-year single center study
G. Mlynarczyk
Acta virologica, 2012
View PDFchevron_right
Non-herpes virus infections after stem cell transplantation and anti-viral immunity
Suparno Chakrabarti
Transplantation Proceedings, 2003
View PDFchevron_right